ClinicalTrials.gg
RecruitingNCT07587931FULLCAN-PRCTUpdated Aug 11, 2026

Concentric vs Eccentric Full Can Exercise in Partial Rotator Cuff Tears

An interventional study of Concentric Full Can Exercise and Eccentric Full Can Exercise in Partial Rotator Cuff Tears, Rotator Cuff Injuries and Shoulder Pain Syndrome, sponsored by Firat University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-08-11.

Sponsored by Firat University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aims to compare the effects of concentric and eccentric full can exercises on supraspinatus muscle architecture in individuals with partial rotator cuff tears.

Rotator cuff tears are a common cause of shoulder pain and functional limitation. The supraspinatus muscle plays a key role in shoulder movement and stability, and its structure may be affected in individuals with partial tears.

Exercise-based rehabilitation is widely used in the conservative management of these conditions. The full can exercise is commonly prescribed to selectively activate the supraspinatus muscle. However, the effects of different contraction types, specifically concentric and eccentric exercises, on muscle structure and clinical outcomes are not fully understood.

In this study, participants will be randomly assigned to either a concentric or eccentric full can exercise group. Both groups will receive a standard physiotherapy program, including therapeutic ultrasound and transcutaneous electrical nerve stimulation (TENS), in addition to the assigned exercise protocol.

The intervention will last for 6 weeks, with sessions performed three times per week. Outcomes will be assessed before and after the intervention.

The primary outcome is the change in supraspinatus muscle pennation angle measured by ultrasound imaging. Secondary outcomes include muscle architecture parameters, pain intensity, range of motion, muscle strength, functional status, and kinesiophobia.

The findings of this study may help improve exercise selection in the rehabilitation of individuals with rotator cuff tears.

Read the detailed description

Study Design and Setting This study is designed as a prospective, randomized, assessor-blinded, parallel-group clinical trial. The study will be conducted at Firat University Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, and Fethi Sekin City Hospital, Department of Physical Medicine and Rehabilitation.

Participants A total of 60 individuals aged between 18 and 65 years with a diagnosis of partial supraspinatus tendon tear confirmed by ultrasound or magnetic resonance imaging will be included. Participants will be randomly allocated into two groups (n=30 per group).

Randomization and Blinding Participants will be assigned to groups using a computer-generated randomization sequence. Allocation will be concealed using sealed, opaque envelopes. Outcome assessments will be performed by a blinded assessor.

Interventions

Both groups will receive a standard physiotherapy program including:

Therapeutic ultrasound Transcutaneous electrical nerve stimulation (TENS) Standard shoulder rehabilitation exercises

The only difference between groups will be the contraction type of the full can exercise:

Concentric Group: Emphasis on the lifting phase (approximately 2 seconds), with minimal eccentric loading Eccentric Group: Emphasis on the lowering phase (approximately 4 seconds), with minimal concentric loading

All interventions will be applied 3 times per week for 6 weeks (total of 18 sessions).

Outcome Measures

Primary Outcome:

Supraspinatus muscle pennation angle measured by B-mode ultrasonography

Secondary Outcomes:

Muscle architecture parameters (fiber length, physiological cross-sectional area) Pain intensity (Visual Analog Scale) Range of motion (goniometric assessment) Muscle strength (hand-held dynamometry) Functional status (DASH, SPADI) Kinesiophobia (Tampa Scale of Kinesiophobia)

Assessments will be performed at baseline (T0) and at the end of the 6-week intervention (T1).

Sample Size and Statistical Analysis Sample size calculation was based on the primary outcome (pennation angle change), assuming an effect size of 0.70, alpha of 0.05, and power of 80%. A minimum of 26 participants per group was required; therefore, 30 participants per group will be recruited to account for potential dropouts.

Data will be analyzed using appropriate statistical methods including mixed-design ANOVA for group and time comparisons. Non-parametric tests will be used if assumptions are not met. Intention-to-treat analysis will be applied.

Ethical Considerations The study will be conducted in accordance with ethical principles for human research. Informed consent will be obtained from all participants prior to inclusion.

02

Conditions studied

  • Partial Rotator Cuff Tears
  • Rotator Cuff Injuries
  • Shoulder Pain Syndrome

Browse trials for

Keywords

  • Supraspinatus Muscle
  • Full Can Exercise
  • Eccentric Exercise
  • Concentric Exercise
  • Shoulder Rehabilitation
  • Muscle Architecture
03

In context

Rotator Cuff Injuries

631 studies on the registry are indexed under Rotator Cuff Injuries; 156 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 456 interventional studies indexed under Rotator Cuff Injuries.

Browse Rotator Cuff Injuries studies →

Lead sponsor

Firat University is the lead sponsor of 117 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18 and 65 years
  • Diagnosed with partial supraspinatus tendon tear confirmed by ultrasound or magnetic resonance imaging
  • Shoulder pain lasting at least 3 months
  • Pain intensity ≥3 on the Visual Analog Scale (VAS)
  • Willing to participate and provide

Exclusion criteria

Exclusion Criteria:

  • Full-thickness rotator cuff tear
  • History of shoulder surgery
  • Shoulder instability
  • Neurological disorders
  • Rheumatological diseases
  • injection within the last 3 months
  • Inability to adhere to the exercise program
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Concentric Exercise Group

    Participants will receive a standard physiotherapy program including ultrasound, TENS, and shoulder rehabilitation exercises, combined with concentric full can exercises. The concentric phase (lifting) will be emphasized, while the eccentric phase will be minimally loaded.

    Other: Concentric Full Can Exercise · Other: Standard Physiotherapy Program

  • Active comparator
    Eccentric Exercise Group

    Participants will receive a standard physiotherapy program including ultrasound, TENS, and shoulder rehabilitation exercises, combined with eccentric full can exercises. The eccentric phase (lowering) will be emphasized, while the concentric phase will be minimally loaded.

    Other: Eccentric Full Can Exercise · Other: Standard Physiotherapy Program

Interventions

  • OtherConcentric Full Can Exercise

    A strengthening exercise performed in the scapular plane with emphasis on the eccentric phase. The lowering phase is performed slowly in approximately 4 seconds against resistance, while the concentric phase is minimized. Exercises are performed 3 times per week for 6 weeks.

  • OtherEccentric Full Can Exercise

    A strengthening exercise performed in the scapular plane with emphasis on the eccentric phase. The lowering phase is performed slowly in approximately 4 seconds against resistance, while the concentric phase is minimized. Exercises are performed 3 times per week for 6 weeks.

  • OtherStandard Physiotherapy Program

    Includes therapeutic ultrasound, transcutaneous electrical nerve stimulation (TENS), and standard shoulder rehabilitation exercises applied to all participants.

06

What researchers measure

Primary outcomes

  1. Change in Supraspinatus Muscle Pennation Angle

    The pennation angle of the supraspinatus muscle will be measured using B-mode ultrasonography. Measurements will be obtained at baseline (T0) and after 6 weeks (T1). The change between time points will be analyzed. Supraspinatus Muscle Pennation Angle: * Assessed by B-mode ultrasonography. * Pennation angle will be measured in degrees (°). * Higher values indicate greater muscle architectural adaptation. * Measured at baseline (T0) and after 6 weeks of intervention (T1).

    Time frame: Baseline and 6 weeks

Secondary outcomes

  1. Change in Supraspinatus Muscle Fiber Length

    Measured using B-mode ultrasonography at baseline and after 6 weeks. Supraspinatus Fascicle Length: * Measured using B-mode ultrasonography in millimeters (mm). * Greater fascicle length may indicate improved muscle architectural properties. * Assessed at baseline and 6 weeks.

    Time frame: Baseline and 6 weeks

  2. Change in Physiological Cross-Sectional Area of Supraspinatus

    Measured via ultrasound imaging at baseline and after 6 weeks. Physiological Cross-Sectional Area (PCSA): * Measured using ultrasonography in cm². * Higher values indicate greater muscle size. * Assessed at baseline and 6 weeks.

    Time frame: Baseline and 6 weeks

  3. Change in Pain Intensity (VAS)

    Pain intensity will be assessed using the Visual Analog Scale (0-10 cm). Visual Analog Scale for Pain: * Pain intensity will be assessed using the Visual Analog Scale (VAS). * The scale ranges from 0 to 10. * 0 indicates no pain and 10 indicates worst imaginable pain. * Higher scores indicate worse pain severity. * Assessed at baseline and 6 weeks.

    Time frame: Baseline and 6 weeks

  4. Change in Shoulder Range of Motion

    Measured using a goniometer for flexion, abduction, internal and external rotation. Shoulder Range of Motion: * Active shoulder flexion, abduction, internal rotation, and external rotation will be measured using a universal goniometer in degrees (°). * Higher values indicate greater joint mobility. * Assessed at baseline and 6 weeks.

    Time frame: Baseline and 6 weeks

  5. Change in Shoulder Muscle Strength

    Measured using a hand-held dynamometer during isometric contraction. Shoulder Muscle Strength * Isometric muscle strength will be assessed using a handheld dynamometer. * Measurements will be recorded in kilograms or Newtons. * Higher values indicate greater muscle strength. * Assessed at baseline and 6 weeks.

    Time frame: Baseline and 6 weeks

  6. Change in Functional Status (DASH Scores)

    Functional status will be assessed using DASH questionnaires. Disabilities of the Arm, Shoulder and Hand (DASH) Score * Functional disability will be assessed using the DASH questionnaire. * Scores range from 0 to 100. * Higher scores indicate greater disability. * Assessed at baseline and 6 weeks.

    Time frame: Baseline and 6 weeks

  7. Change in Functional Status (SPADI Scores)

    Functional status will be assessed using SPADI questionnaires. Shoulder Pain and Disability Index (SPADI): * Shoulder-related pain and disability will be assessed using SPADI. * Scores range from 0 to 100. * Higher scores indicate greater pain and disability. * Assessed at baseline and 6 weeks.

    Time frame: Baseline and 6 weeks

  8. Change in Kinesiophobia (Tampa Scale)

    Measured using the Tampa Scale of Kinesiophobia. Tampa Scale for Kinesiophobia: * Fear of movement will be assessed using the Tampa Scale for Kinesiophobia. * Scores range from 17 to 68. * Higher scores indicate greater kinesiophobia. * Assessed at baseline and 6 weeks.

    Time frame: Baseline and 6 weeks

07

Study locations

1 of 1 sites recruiting
  • Firat University
    Elâzığ, MErkez 23200, Turkey (Türkiye)
    Recruiting
    • Muharrem Gökhan Beydağı, PhD · Contactmgbeydagi@firat.edu.tr · 05323581105
    • Muhammet Şahin Elbastı, MD · Contact
    • Muhammet Şahin Elbastı, MD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Nov 2026, 4 months later.

Of 228 non-industry interventional studies with no phase under Rotator Cuff Injuries, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 4 months is below that.

Counting every sponsor, half of 252 studies reached it within 23 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 27, 2026
First posted
May 14, 2026
StartEst.
Jul 20, 2026
Primary completionEst.
Nov 20, 2026
CompletionEst.
Nov 20, 2027
Last update
Aug 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07587931
Lead sponsor
Firat University
Collaborators
Elazıg Fethi Sekin Sehir Hastanesi
Responsible party
Muharrem Gökhan Beydağı (Assistant Professor, PhD, Firat University) — Principal investigator
First posted
May 14, 2026
Start date
Jul 20, 2026 (estimated)
Primary completion
Nov 20, 2026 (estimated)
Completion
Nov 20, 2027 (estimated)
Last update
Aug 11, 2026

Study contacts

Muharrem Gökhan Beydağı, PhD
Contact
mgbeydagi@firat.edu.tr
+905323581105

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion